Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Dawson

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancerArif Hussain, Nancy Dawson, Pradip Amin, et al.
Southern Medical Journal|May 4, 2021
Discharge Summary Completion Timeliness and the Association of 30-Day ReadmissionPatricia Lewis, Kathryn Braddock, Leila Tolaymat, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancerSteven J Dibiase, Arif Hussain, Ritesh Kataria, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in patients with recurrent prostate cancerDiana V Kouiavskaia, Carla A Berard, Ellen Datena, et al.
Southern Medical Journal|March 9, 2016
Feasibility of Canine Therapy Among Hospitalized Pre-Heart Transplant PatientsDavid Snipelisky, Katherine Duello, Shawn Gallup, et al.
Southern Medical Journal|March 2, 2023
Dermatology Residency Applicant Self-Reported Stressors and Coping Mechanisms by Sex, Race, and Geographic Region during the 2020-2021 Application CycleLeila M Tolaymat, Ashley L Walker, Mingyuan Yin, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without prior prostatectomyArif Hussain, Yin Wu, Alireza Mirmiran, et al.
Southern Medical Journal|February 3, 2018
Association of Anemia with Outcomes of Acute Heart FailureAhmad Halawa, M Caroline Burton, Michael J Maniaci, et al.
Cureus|January 29, 2024
Virtual Academic Asynchronous Mentoring (VAAM) for Faculty Physicians: An Innovative MentorshipMingyuan Yin, Mindy McManus, Nancy Dawson, et al.
Patient Education and Counseling|May 13, 2026
Understanding the information-seeking behaviors and office visit communication experiences of patients with breast and prostate cancer: A framework for supporting informed decision-makingIlona Fridman, Maame Duah, Diya Vemuganti, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancerArif Hussain, Nancy Dawson, Pradip Amin, et al.
Southern Medical Journal|May 4, 2021
Discharge Summary Completion Timeliness and the Association of 30-Day ReadmissionPatricia Lewis, Kathryn Braddock, Leila Tolaymat, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancerSteven J Dibiase, Arif Hussain, Ritesh Kataria, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in patients with recurrent prostate cancerDiana V Kouiavskaia, Carla A Berard, Ellen Datena, et al.
Southern Medical Journal|March 9, 2016
Feasibility of Canine Therapy Among Hospitalized Pre-Heart Transplant PatientsDavid Snipelisky, Katherine Duello, Shawn Gallup, et al.
Southern Medical Journal|March 2, 2023
Dermatology Residency Applicant Self-Reported Stressors and Coping Mechanisms by Sex, Race, and Geographic Region during the 2020-2021 Application CycleLeila M Tolaymat, Ashley L Walker, Mingyuan Yin, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without prior prostatectomyArif Hussain, Yin Wu, Alireza Mirmiran, et al.
Southern Medical Journal|February 3, 2018
Association of Anemia with Outcomes of Acute Heart FailureAhmad Halawa, M Caroline Burton, Michael J Maniaci, et al.
Cureus|January 29, 2024
Virtual Academic Asynchronous Mentoring (VAAM) for Faculty Physicians: An Innovative MentorshipMingyuan Yin, Mindy McManus, Nancy Dawson, et al.
Patient Education and Counseling|May 13, 2026
Understanding the information-seeking behaviors and office visit communication experiences of patients with breast and prostate cancer: A framework for supporting informed decision-makingIlona Fridman, Maame Duah, Diya Vemuganti, et al.
Pageof 3